Vanguard Group Inc Alx Oncology Holdings Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,884,573 shares of ALXO stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,884,573
Previous 1,727,248 9.11%
Holding current value
$2.43 Million
Previous $10.4 Million 67.08%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.81 - $8.13 $284,758 - $1.28 Million
157,325 Added 9.11%
1,884,573 $3.43 Million
Q2 2024

Aug 13, 2024
BUY
$5.84 - $17.56 $938,978 - $2.82 Million
160,784 Added 10.26%
1,727,248 $10.4 Million
Q1 2024

May 10, 2024
BUY
$10.95 - $16.79 $701,402 - $1.08 Million
64,055 Added 4.26%
1,566,464 $17.5 Million
Q4 2023

Feb 14, 2024
BUY
$4.81 - $15.38 $2.38 Million - $7.6 Million
494,173 Added 49.01%
1,502,409 $22.4 Million
Q3 2023

Nov 14, 2023
BUY
$4.19 - $7.35 $6,905 - $12,112
1,648 Added 0.16%
1,008,236 $4.84 Million
Q2 2023

Aug 14, 2023
SELL
$4.37 - $9.56 $126,515 - $276,771
-28,951 Reduced 2.8%
1,006,588 $7.56 Million
Q1 2023

May 15, 2023
SELL
$4.52 - $11.71 $1.76 Million - $4.56 Million
-389,759 Reduced 27.35%
1,035,539 $4.68 Million
Q4 2022

Feb 10, 2023
BUY
$9.51 - $12.95 $135,888 - $185,042
14,289 Added 1.01%
1,425,298 $16.1 Million
Q3 2022

Nov 14, 2022
BUY
$8.23 - $15.14 $710,018 - $1.31 Million
86,272 Added 6.51%
1,411,009 $13.5 Million
Q2 2022

Aug 12, 2022
SELL
$5.89 - $19.46 $2.07 Million - $6.83 Million
-350,919 Reduced 20.94%
1,324,737 $10.7 Million
Q1 2022

May 13, 2022
SELL
$13.65 - $22.06 $441,959 - $714,258
-32,378 Reduced 1.9%
1,675,656 $28.3 Million
Q4 2021

Feb 14, 2022
BUY
$21.49 - $74.4 $612,593 - $2.12 Million
28,506 Added 1.7%
1,708,034 $36.7 Million
Q3 2021

Nov 12, 2021
BUY
$52.51 - $80.91 $6.82 Million - $10.5 Million
129,810 Added 8.38%
1,679,528 $124 Million
Q2 2021

Aug 13, 2021
BUY
$52.2 - $75.23 $80.9 Million - $117 Million
1,549,718 New
1,549,718 $84.7 Million

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $52.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email